Monday, January 16, 2023

DCGI approves market authorisation for SII#39;s Covid vaccine Covovax as heterologous booster dose

DCGI approves market authorisation for SII#39;s Covid vaccine Covovax as heterologous booster dose The DCGI#39;s approval came following recommendation by the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO).

from Moneycontrol Business News https://ift.tt/qyeKhpP

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...